Phosphatidylethanol (PEth) is a group of abnormal phospholipids formed only in the presence of ethanol. The analysis of PEth in blood, often referred to by the test used to detect it, offers a highly specific and sensitive biomarker for recent alcohol consumption. Unlike other common alcohol markers, PEth is not influenced by liver disease, medication, or other factors unrelated to alcohol intake. Its presence in the blood indicates that alcohol has been consumed, with the level often correlating to the quantity ingested.
The assessment of this phospholipid provides a distinct advantage in accurately detecting alcohol use because of its formation process and relatively long detection window. It can identify alcohol consumption that may be missed by traditional methods like breathalyzers or urine tests. Historically, relying on self-reporting or less specific biomarkers posed challenges in accurately assessing alcohol habits. PEth testing enhances the ability to monitor abstinence in treatment programs, verify compliance in legal settings, and provide objective data for clinical assessments.